Products & ReviewClinical Diagnostics

HPV-Risk assay

Fujirebio81353Available: ,Western Europe,Asia,Eastern Europe,South Central America,Middle East,Africa,

Qualitative detection of 14 high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68) as well as putative HPV high risk type 67, with separate identification of HPV16 and 18 in one test. Fully clinically validated HPV screening method to identify women at risk for cervical (pre)cancer using either cervical scrape or self-collected vaginal sample.

Request Pricing
Fujirebio

Receive your quote directly from the manufacturer.

Ease of Use
After Sales Service
Value for Money
Write your own review

Design based on E7 target region:

  • Overcomes potential false-negative results caused by viral DNA integration during cancer development

HPV types detected:

  • 14 hrHPV types: HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68 as well as putative HPV high risk type 67

Fully clinically validated:

  • Compliance to International Screening Guidelines for HPV DNA tests1,2,3

Flexible:

  • Suitable for different sample types including self-collected samples
  • Compatible with common DNA extraction methods

Reliable:

  • Build-in check for sample quality ensuring reliable results

Easy:

  • Limited hands-on time due to the ready-to-use master mix

Product Overview

Links